Regulatory Open Forum

 View Only
Reg Intel Conference 2024
Back to discussions
Expand all | Collapse all

Digital therapeutics subject to new guidelines in Korea

  • 1.  Digital therapeutics subject to new guidelines in Korea

    Posted 26-Oct-2020 17:24
    Medical software programs used to prevent, manage, or treat diseases based on clinical evidence are subject to new guidelines for obtaining the approval of regulators in Korea. The guidelines on the digital therapeutics programs cover their definition and scope, criteria for product samples, and technical document writing.

    ------------------------------
    Ames Gross
    President
    Pacific Bridge Medical
    Bethesda, MD
    www.pacificbridgemedical.com
    contact@pacificbridgemedical.com
    ------------------------------


Related Content